You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 7, 2024

Lanthanum carbonate - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for lanthanum carbonate and what is the scope of patent protection?

Lanthanum carbonate is the generic ingredient in two branded drugs marketed by Takeda Pharms Usa, Barr, Invagen Pharms, and Natco Pharma Ltd, and is included in five NDAs. There are four patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Lanthanum carbonate has ninety-one patent family members in thirty-one countries.

There are nine drug master file entries for lanthanum carbonate. Six suppliers are listed for this compound.

Drug Prices for lanthanum carbonate

See drug prices for lanthanum carbonate

Recent Clinical Trials for lanthanum carbonate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Medical Universtity of LodzPhase 4
Medical University of LodzPhase 4
Universitair Ziekenhuis BrusselPhase 3

See all lanthanum carbonate clinical trials

Pharmacology for lanthanum carbonate
Drug ClassPhosphate Binder
Mechanism of ActionPhosphate Chelating Activity
Paragraph IV (Patent) Challenges for LANTHANUM CARBONATE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
FOSRENOL Oral Powder lanthanum carbonate 750 mg and 1000 mg 204734 1 2015-11-25
FOSRENOL Chewable Tablet lanthanum carbonate 500 mg, 750 mg and 1000 mg 021468 3 2008-10-27

US Patents and Regulatory Information for lanthanum carbonate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Invagen Pharms LANTHANUM CARBONATE lanthanum carbonate TABLET, CHEWABLE;ORAL 206868-002 Jan 24, 2022 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Takeda Pharms Usa FOSRENOL lanthanum carbonate TABLET, CHEWABLE;ORAL 021468-004 Nov 23, 2005 AB RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Barr LANTHANUM CARBONATE lanthanum carbonate TABLET, CHEWABLE;ORAL 090977-002 Jan 27, 2022 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Natco Pharma Ltd LANTHANUM CARBONATE lanthanum carbonate TABLET, CHEWABLE;ORAL 090978-001 Aug 11, 2017 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Takeda Pharms Usa FOSRENOL lanthanum carbonate POWDER;ORAL 204734-002 Sep 24, 2014 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Takeda Pharms Usa FOSRENOL lanthanum carbonate TABLET, CHEWABLE;ORAL 021468-001 Oct 26, 2004 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Takeda Pharms Usa FOSRENOL lanthanum carbonate TABLET, CHEWABLE;ORAL 021468-003 Nov 23, 2005 AB RX Yes No ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for lanthanum carbonate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Takeda Pharms Usa FOSRENOL lanthanum carbonate TABLET, CHEWABLE;ORAL 021468-002 Oct 26, 2004 ⤷  Sign Up ⤷  Sign Up
Takeda Pharms Usa FOSRENOL lanthanum carbonate TABLET, CHEWABLE;ORAL 021468-001 Oct 26, 2004 ⤷  Sign Up ⤷  Sign Up
Takeda Pharms Usa FOSRENOL lanthanum carbonate POWDER;ORAL 204734-001 Sep 24, 2014 ⤷  Sign Up ⤷  Sign Up
Takeda Pharms Usa FOSRENOL lanthanum carbonate TABLET, CHEWABLE;ORAL 021468-001 Oct 26, 2004 ⤷  Sign Up ⤷  Sign Up
Takeda Pharms Usa FOSRENOL lanthanum carbonate TABLET, CHEWABLE;ORAL 021468-004 Nov 23, 2005 ⤷  Sign Up ⤷  Sign Up
Takeda Pharms Usa FOSRENOL lanthanum carbonate POWDER;ORAL 204734-002 Sep 24, 2014 ⤷  Sign Up ⤷  Sign Up
Takeda Pharms Usa FOSRENOL lanthanum carbonate TABLET, CHEWABLE;ORAL 021468-003 Nov 23, 2005 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for lanthanum carbonate

Country Patent Number Title Estimated Expiration
Hungary E029382 ⤷  Sign Up
Cyprus 1117082 ⤷  Sign Up
European Patent Office 2645995 CAPSULE ET FORMULATIONS DE POUDRE CONTENANT DES COMPOSÉS DE LANTHANE (CAPSULE AND POWDER FORMULATIONS CONTAINING LANTHANUM COMPOUNDS) ⤷  Sign Up
Austria 460169 ⤷  Sign Up
Spain 2478258 ⤷  Sign Up
Portugal 2172205 ⤷  Sign Up
China 103237543 Capsule and powder formulations containing lanthanum compounds ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.